2m 2m 2m 2m 2m 2m 2m
KINIKSA PHARMA (KNSA)
NASDAQ
$59.39+$2.26 (+3.96%)
Price as of Jun 23, 2026 5:57 PM EDT- $2.4BMarket Cap
- 98.92%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
KINIKSA PHARMA (KNSA)
$59.39+$2.26 (+3.96%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 677.6M +60.09% | 423.2M +56.60% | 270.3M +22.74% | 220.2M +471.24% | |
Cost of Revenue | 77.7M +27.52% | 60.9M -34.64% | 93.2M +98.43% | 47.0M +416.11% | |
Gross Profit | 599.9M +65.57% | 362.3M +104.63% | 177.1M +2.22% | 173.2M +488.28% | |
Sales and Marketing Expense | 196.3M +16.82% | 168.0M +29.81% | 129.4M +32.13% | 98.0M +13.97% | |
Research and Development Expense | -96.9M -13.23% | -111.6M +46.69% | -76.1M +16.20% | -65.5M -34.05% | |
Depreciation and Amortization Expense | 1.6M -8.32% | 1.7M -27.60% | 2.3M -2.54% | 2.4M +2.00% | |
Total Operating Expenses | 77.7M +27.52% | 60.9M -34.64% | 93.2M +98.43% | 47.0M +416.11% | |
Operating Profit | 77.2M +269.28% | -45.6M +81.04% | -25.2M -357.81% | 9.8M +106.24% | |
Interest Income | 11.6M +23.07% | 9.5M +10.77% | 8.5M +581.88% | 1.3M +1,191.75% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 11.6M +23.07% | 9.5M +10.77% | 8.5M +581.88% | 1.3M +1,191.75% | |
Total Nonoperating Income and Expense | 11.6M +23.07% | 9.5M +10.77% | 8.5M +581.88% | 1.3M N/A | |
Income before Taxes | 88.9M +345.82% | -36.2M +117.10% | -16.7M -251.02% | 11.0M +107.04% | |
Income Taxes | 29.9M +324.13% | 7.0M +122.91% | -30.7M -82.17% | -172.3M -12,543.10% | |
Extraordinary Items | 0 N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 59.0M +236.61% | -43.2M -406.68% | 14.1M -92.32% | 183.4M +216.11% | |
Net Income from Continuing Operations Applicable to Common | 88.9M +345.82% | -36.2M +117.10% | -16.7M -251.02% | 11.0M +107.04% | |
Basic EPS and Net Income | 0.80 +233.33% | -0.60 -400.00% | 0.20 -92.42% | 2.64 +214.78% | |
Diluted EPS and Net Income | 0.75 +225.00% | -0.60 -400.00% | 0.20 -92.31% | 2.60 +213.04% | |
Basic Weighted Average Shares | 74.2M +3.89% | 71.4M +1.95% | 70.1M +0.98% | 69.4M +1.17% | |
Diluted Weighted Average Shares | 79.0M +10.58% | 71.4M -0.69% | 71.9M +2.13% | 70.4M +2.69% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 165.6M -9.80% | 183.6M +70.05% | 108.0M -12.03% | 122.7M +0.20% | |
Short-Term Investments | 248.5M +313.81% | 60.0M -38.99% | 98.4M +44.96% | 67.9M +13.66% | |
Cash and Cash Equivalents and Short-Term Investments | 414.1M +69.96% | 243.6M +18.05% | 206.4M +8.27% | 190.6M +4.61% | |
Total Current Assets | 527.2M +58.88% | 331.8M +20.09% | 276.3M +13.67% | 243.1M +23.73% | |
Accumulated Depreciation | 7.2M -11.75% | 8.2M +5.24% | 7.8M +13.50% | 6.9M +15.96% | |
Property and Plant and Equipment and Net | 1.9M +193.50% | 662,000 -9.81% | 734,000 -55.73% | 1.7M -41.50% | |
Total Long-Term Assets | 11.3M +9.62% | 10.3M +1,147.28% | 827,000 -85.80% | 5.8M -33.21% | |
Total Assets | 763.6M +31.54% | 580.6M +10.30% | 526.3M +14.50% | 459.7M +97.45% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 139.2M +38.33% | 100.6M +58.05% | 63.7M +35.27% | 47.1M +5.00% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 18.5M +916.02% | 1.8M -1.88% | 1.9M +1.03% | 1.8M +581.11% | |
Total Liabilities | 196.0M +37.93% | 142.1M +62.45% | 87.5M +37.72% | 63.5M +33.00% | |
Retained Earnings | -462.1M -11.32% | -521.1M +9.04% | -477.9M -2.86% | -492.0M -27.15% | |
Total Stockholders Equity | 567.6M +29.46% | 438.4M -0.09% | 438.8M +10.78% | 396.1M +114.09% | |
Total Shares Outstanding | 45.7M -37.04% | 72.5M +2.92% | 70.5M +1.09% | 69.7M +0.92% | |
Cash Flow | |||||
Cash from Operating Activities | 138.0M +437.14% | 25.7M +93.14% | 13.3M +129.05% | 5.8M +104.60% | |
Capital Expenditures | 1.6M +466.06% | 277,000 +113.08% | 130,000 +23.81% | 105,000 -74.70% | |
Cash from Investing Activities | -189.0M -601.68% | 37.7M +227.46% | -29.6M +265.90% | -8.1M -106.28% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 33.0M +169.22% | 12.3M +720.47% | 1.5M -40.58% | 2.5M -57.25% | |
Financials Ratio | |||||
Gross Margin | 88.54% +3.42% | 85.61% +30.67% | 65.52% -16.72% | 78.67% +2.98% | |
Operating Margin | 11.40% +205.74% | -10.78% +15.61% | -9.32% -310.04% | 4.44% +101.09% | |
Return on Assets | 8.78% +212.49% | -7.80% -373.19% | 2.86% -94.61% | 52.96% +197.63% | |
Return on Equity | 11.73% +219.12% | -9.85% -391.90% | 3.37% -94.65% | 63.10% +199.28% | |
Revenue Growth | 60.09% +6.16% | 56.61% +148.87% | 22.74% -95.17% | 471.24% N/A | |
Current Ratio | 3.79 +14.86% | 3.30 -24.02% | 4.34 -15.96% | 5.16 +17.83% | |
Cash Ratio | 1.19 -34.79% | 1.82 +7.60% | 1.70 -34.97% | 2.61 -4.57% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow